MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$183K
Free Cash flow
$2,743K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Prepaid expenses and other asset...
Accounts receivable
Accrued and other liabilities
Others
Negative Cash Flow Breakdown
Net loss
Accounts payable
Purchases of investments
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-13,494
5,179
55,045
-8,141
Depreciation and amortization
741
1,126
2,055
2,080
Loss on sale of property and equipment
8
-10
-33
-5
Net accretion of discounts on investments
84
56
71
42
Gain on modification of lease liability
-
-
1,005
-
Stock-based compensation
1,290
1,482
1,716
2,018
Change in fair value of equity-linked instrument
-341
-
-
-
Non-cash interest expense related to sale of future royalties
538
505
546
607
Non-cash revenue related to sale of future royalties
41
331
0
0
Accounts receivable
-7,128
-7,425
-28,152
38,435
Unbilled receivable from government contracts
-3,454
13,654
-6,448
6,448
Prepaid expenses and other assets
-7,326
-7,889
18,054
-417
Prepaid clinical services, long-term
-
-
-34,898
0
Accounts payable
-7,297
2,674
-31,579
42,570
Deferred revenue-Government Contract
39
-45
-64,760
-549
Deferred revenue-Collaboration Revenue
-2,919
-2,815
14,976
-
Other accrued liabilities
-
-
-
8,513
Accrued and other liabilities
5,764
-11,443
33,735
-
Net cash provided by (used in) operating activities
2,778
-2,054
30,663
2,595
Purchases of property and equipment
35
448
1
117
Proceeds from sale of property and equipment
10
3
0
5
Purchases of investments
5,571
10,231
4,010
9,410
Proceeds from maturities of investments
2,880
10,000
6,000
3,700
Net cash (used in) provided by investing activities
-2,716
-676
1,989
-5,822
Net proceeds from issuance of common stock-Ra Capital Healthcare Fund2025
-
-
4,201
-
Net proceeds from issuance of common stock-June2024Offering
-
-
0
0
Net proceeds from issuance of common stock through at-the-market facilities-Atthemarket Facility
0
-
0
0
Issuance cost of equity line of credit commitment shares
167
-
-
-
Net proceeds from issuance of common stock-RACapital Healthcare Fund2024
-
-
0
0
Net proceeds from issuance of common stock through at-the-market facilities-Equity Line Of Credit
44
-
-
-
Proceeds from issuance of common stock upon exercise of stock options
57
0
0
0
Shares acquired to settle employee tax withholding liabilities
26
338
21
4
Proceeds from issuance of common stock under the employee stock purchase plan
-
-
0
0
Proceeds from issuance of treasury stock under the employee stock purchase plan
213
-
102
0
Net cash used in financing activities
121
-338
4,282
-4
Net decrease in cash and cash equivalents
183
-3,068
36,934
-3,231
Cash and cash equivalents at beginning of the period
50,746
53,814
16,880
25,229
Cash and cash equivalents at end of the period
50,929
50,746
53,814
16,880
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Prepaid expenses and
other assets
-$7,326K
(-377.57%↓ Y/Y)
Proceeds from issuance of
treasury stock under the...
$213K
(169.62%↑ Y/Y)
Accounts receivable
-$7,128K
(-381.62%↓ Y/Y)
Accrued and other
liabilities
$5,764K
Unbilled receivable from
government contracts
-$3,454K
(-111.30%↓ Y/Y)
Stock-based compensation
$1,290K
(-71.83%↓ Y/Y)
Depreciation and
amortization
$741K
(-83.33%↓ Y/Y)
Non-cash interest
expense related to sale...
$538K
(-67.78%↓ Y/Y)
Change in fair value of
equity-linked instrument
-$341K
Deferred
revenue-Government Contract
$39K
(269.57%↑ Y/Y)
Proceeds from issuance of
common stock upon...
$57K
(1800.00%↑ Y/Y)
Net proceeds from
issuance of common stock...
$44K
Net cash provided by
(used in) operating...
$2,778K
(110.88%↑ Y/Y)
Net cash used in
financing activities
$121K
(410.26%↑ Y/Y)
Canceled cashflow
$23,843K
Canceled cashflow
$193K
Net decrease in cash
and cash...
$183K
(103.58%↑ Y/Y)
Canceled cashflow
$2,716K
Net loss
-$13,494K
(55.87%↑ Y/Y)
Accounts payable
-$7,297K
(-300.03%↓ Y/Y)
Deferred
revenue-Collaboration Revenue
-$2,919K
Net accretion of
discounts on investments
$84K
(-49.09%↓ Y/Y)
Non-cash revenue related
to sale of future...
$41K
(-99.09%↓ Y/Y)
Loss on sale of
property and equipment
$8K
Proceeds from maturities
of investments
$2,880K
(-90.50%↓ Y/Y)
Proceeds from sale of
property and equipment
$10K
Issuance cost of equity
line of credit...
$167K
Shares acquired to
settle employee tax...
$26K
(-85.06%↓ Y/Y)
Net cash (used in)
provided by investing...
-$2,716K
(-113.27%↓ Y/Y)
Canceled cashflow
$2,890K
Purchases of investments
$5,571K
(-43.20%↓ Y/Y)
Purchases of property and
equipment
$35K
(29.63%↑ Y/Y)
Buy us a coffee
Vaxart, Inc. (VXRT)
Vaxart, Inc. (VXRT)